Claims
- 1. A material for purification of physiological liquids of organism, comprising a polymeric material which has a size, a shape, and a structure selected so as to remove toxic compounds from the physiological liquid and is composed of a partially chloromethylated porous highly crosslinked styrene or divinylbenzene copolymer which initially have surface exposed chloromethyl groups in which thereafter chlorine is replaced with an element which forms different surface exposed functional groups with a greater hydrophilicity and greater biocompatibility than that of chloromethyl groups.
- 2. A material as defined in claim 1, wherein said polymeric material has polymer beads with mainly unsubstituted hydrophobic interior which is responsible for removing of toxic compounds in a molecular range of 300 to 2000 Dalton.
- 3. A material as defined in claim 1, wherein said porous highly crosslinked styrene or divinylbenzene copolymer is a macroporous or mesoporous styrene-divinylbenzene-ethylstyrene copolymer subjected to a partial chloromethylation to a chlorine content of up to 7% molecular weight.
- 4. A material as defined in claim 1, wherein said porous highly crosslinked styrene or divinylbenzene copolymer is a hypercrosslinked polystyrene produced from crosslinked styrene copolymers by an extensive chloromethylation and a subsequent post-crosslinking by treating with a Friedel-Crafts catalyst in a swollen state.
- 5. A material as defined in claim 1, wherein said porous highly crosslinked styrene or divinylbenzene copolymer is a hypercrosslinked polystyrene produced from crosslinked styrene copolymers by an extensive additional post-crosslinking in a swollen state with bifunctional crosslinking agents selected from the group comprising of monochlorodimethyl ether and p-xylilene dichloride.
- 6. A material as defined in claim 1, wherein said surface exposed functional groups of greater hydrophilicity and enhanced biocompatibility are covalently bonded or electrostatically deposited long polymeric chains selected from the group consisting of heparine,
CROSS-REFERENCE TO A RELATED APPLICATION
This application is a division of application Ser. No. 09/019,584 filed on Feb. 6, 1998, now allowed U.S. Pat. No. 6,136,424.
US Referenced Citations (6)
Number |
Name |
Date |
Kind |
4908405 |
Bayer et al. |
Mar 1990 |
A |
5037857 |
Maroldo et al. |
Aug 1991 |
A |
5079274 |
Schneider et al. |
Jan 1992 |
A |
5683800 |
Stringfield et al. |
Nov 1997 |
A |
5773384 |
Davankov et al. |
Jun 1998 |
A |
6136424 |
Davankov et al. |
Oct 2000 |
A |
Foreign Referenced Citations (2)
Number |
Date |
Country |
249274 |
Sep 1987 |
DE |
249703 |
Sep 1987 |
DE |